N J Hawkins - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

N J Hawkins

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Oncogene|November 15, 1997

Developmentally-regulated expression of murine K-ras isoformsS Pells, M Divjak, P Romanowski, et al.

Journal of Cancer Research and Clinical Oncology|September 12, 2014

Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signallingC Henry, A Quadir, N J Hawkins, et al.

Clinical Chemistry|May 5, 2000

Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimizationC J Fuery, H L Impey, N J Roberts, et al.

British Journal of Cancer|February 20, 2014

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomasS Deb, H Xu, J Tuynman, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001

Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancerR L Ward, D Packham, A M Smythe, et al.

Oncogene|October 23, 2012

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesisM Christie, R N Jorissen, D Mouradov, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Oncogene|November 15, 1997

Developmentally-regulated expression of murine K-ras isoformsS Pells, M Divjak, P Romanowski, et al.

Journal of Cancer Research and Clinical Oncology|September 12, 2014

Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signallingC Henry, A Quadir, N J Hawkins, et al.

Clinical Chemistry|May 5, 2000

Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimizationC J Fuery, H L Impey, N J Roberts, et al.

British Journal of Cancer|February 20, 2014

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomasS Deb, H Xu, J Tuynman, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001

Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancerR L Ward, D Packham, A M Smythe, et al.

Oncogene|October 23, 2012

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesisM Christie, R N Jorissen, D Mouradov, et al.

Pageof 4